Cargando…

Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review

PURPOSE: Clinical guidelines’ (CGs) adherence supports high-quality care. However, healthcare providers do not always comply with CGs recommendations. This systematic literature review aims to assess the extent of healthcare providers’ adherence to breast cancer CGs in Europe and to identify the fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Niño de Guzmán, Ena, Song, Yang, Alonso-Coello, Pablo, Canelo-Aybar, Carlos, Neamtiu, Luciana, Parmelli, Elena, Pérez-Bracchiglione, Javier, Rabassa, Montserrat, Rigau, David, Parkinson, Zuleika Saz, Solà, Iván, Vásquez-Mejía, Adrián, Ricci-Cabello, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220981/
https://www.ncbi.nlm.nih.gov/pubmed/32378052
http://dx.doi.org/10.1007/s10549-020-05657-8
_version_ 1783533272961122304
author Niño de Guzmán, Ena
Song, Yang
Alonso-Coello, Pablo
Canelo-Aybar, Carlos
Neamtiu, Luciana
Parmelli, Elena
Pérez-Bracchiglione, Javier
Rabassa, Montserrat
Rigau, David
Parkinson, Zuleika Saz
Solà, Iván
Vásquez-Mejía, Adrián
Ricci-Cabello, Ignacio
author_facet Niño de Guzmán, Ena
Song, Yang
Alonso-Coello, Pablo
Canelo-Aybar, Carlos
Neamtiu, Luciana
Parmelli, Elena
Pérez-Bracchiglione, Javier
Rabassa, Montserrat
Rigau, David
Parkinson, Zuleika Saz
Solà, Iván
Vásquez-Mejía, Adrián
Ricci-Cabello, Ignacio
author_sort Niño de Guzmán, Ena
collection PubMed
description PURPOSE: Clinical guidelines’ (CGs) adherence supports high-quality care. However, healthcare providers do not always comply with CGs recommendations. This systematic literature review aims to assess the extent of healthcare providers’ adherence to breast cancer CGs in Europe and to identify the factors that impact on healthcare providers’ adherence. METHODS: We searched for systematic reviews and quantitative or qualitative primary studies in MEDLINE and Embase up to May 2019. The eligibility assessment, data extraction, and risk of bias assessment were conducted by one author and cross-checked by a second author. We conducted a narrative synthesis attending to the modality of the healthcare process, methods to measure adherence, the scope of the CGs, and population characteristics. RESULTS: Out of 8137 references, we included 41 primary studies conducted in eight European countries. Most followed a retrospective cohort design (19/41; 46%) and were at low or moderate risk of bias. Adherence for overall breast cancer care process (from diagnosis to follow-up) ranged from 54 to 69%; for overall treatment process [including surgery, chemotherapy (CT), endocrine therapy (ET), and radiotherapy (RT)] the median adherence was 57.5% (interquartile range (IQR) 38.8–67.3%), while for systemic therapy (CT and ET) it was 76% (IQR 68–77%). The median adherence for the processes assessed individually was higher, ranging from 74% (IQR 10–80%), for the follow-up, to 90% (IQR 87–92.5%) for ET. Internal factors that potentially impact on healthcare providers’ adherence were their perceptions, preferences, lack of knowledge, or intentional decisions. CONCLUSIONS: A substantial proportion of breast cancer patients are not receiving CGs-recommended care. Healthcare providers’ adherence to breast cancer CGs in Europe has room for improvement in almost all care processes. CGs development and implementation processes should address the main factors that influence healthcare providers' adherence, especially patient-related ones. REGISTRATION: PROSPERO (CRD42018092884). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-020-05657-8) contains supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-7220981
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-72209812020-05-15 Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review Niño de Guzmán, Ena Song, Yang Alonso-Coello, Pablo Canelo-Aybar, Carlos Neamtiu, Luciana Parmelli, Elena Pérez-Bracchiglione, Javier Rabassa, Montserrat Rigau, David Parkinson, Zuleika Saz Solà, Iván Vásquez-Mejía, Adrián Ricci-Cabello, Ignacio Breast Cancer Res Treat Review PURPOSE: Clinical guidelines’ (CGs) adherence supports high-quality care. However, healthcare providers do not always comply with CGs recommendations. This systematic literature review aims to assess the extent of healthcare providers’ adherence to breast cancer CGs in Europe and to identify the factors that impact on healthcare providers’ adherence. METHODS: We searched for systematic reviews and quantitative or qualitative primary studies in MEDLINE and Embase up to May 2019. The eligibility assessment, data extraction, and risk of bias assessment were conducted by one author and cross-checked by a second author. We conducted a narrative synthesis attending to the modality of the healthcare process, methods to measure adherence, the scope of the CGs, and population characteristics. RESULTS: Out of 8137 references, we included 41 primary studies conducted in eight European countries. Most followed a retrospective cohort design (19/41; 46%) and were at low or moderate risk of bias. Adherence for overall breast cancer care process (from diagnosis to follow-up) ranged from 54 to 69%; for overall treatment process [including surgery, chemotherapy (CT), endocrine therapy (ET), and radiotherapy (RT)] the median adherence was 57.5% (interquartile range (IQR) 38.8–67.3%), while for systemic therapy (CT and ET) it was 76% (IQR 68–77%). The median adherence for the processes assessed individually was higher, ranging from 74% (IQR 10–80%), for the follow-up, to 90% (IQR 87–92.5%) for ET. Internal factors that potentially impact on healthcare providers’ adherence were their perceptions, preferences, lack of knowledge, or intentional decisions. CONCLUSIONS: A substantial proportion of breast cancer patients are not receiving CGs-recommended care. Healthcare providers’ adherence to breast cancer CGs in Europe has room for improvement in almost all care processes. CGs development and implementation processes should address the main factors that influence healthcare providers' adherence, especially patient-related ones. REGISTRATION: PROSPERO (CRD42018092884). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10549-020-05657-8) contains supplementary material, which is available to authorised users. Springer US 2020-05-06 2020 /pmc/articles/PMC7220981/ /pubmed/32378052 http://dx.doi.org/10.1007/s10549-020-05657-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Niño de Guzmán, Ena
Song, Yang
Alonso-Coello, Pablo
Canelo-Aybar, Carlos
Neamtiu, Luciana
Parmelli, Elena
Pérez-Bracchiglione, Javier
Rabassa, Montserrat
Rigau, David
Parkinson, Zuleika Saz
Solà, Iván
Vásquez-Mejía, Adrián
Ricci-Cabello, Ignacio
Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
title Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
title_full Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
title_fullStr Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
title_full_unstemmed Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
title_short Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
title_sort healthcare providers’ adherence to breast cancer guidelines in europe: a systematic literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220981/
https://www.ncbi.nlm.nih.gov/pubmed/32378052
http://dx.doi.org/10.1007/s10549-020-05657-8
work_keys_str_mv AT ninodeguzmanena healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT songyang healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT alonsocoellopablo healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT caneloaybarcarlos healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT neamtiuluciana healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT parmellielena healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT perezbracchiglionejavier healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT rabassamontserrat healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT rigaudavid healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT parkinsonzuleikasaz healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT solaivan healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT vasquezmejiaadrian healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview
AT riccicabelloignacio healthcareprovidersadherencetobreastcancerguidelinesineuropeasystematicliteraturereview